Evaluation of the skin irritancy and corrosivity potential of an ingredient is a necessity in the safety assessment of cosmetic ingredients. To date, there are two formally validated alternatives to the rabbit Draize test for skin corrosivity in place, namely the rat skin transcutaneous electrical resistance (TER) assay and the Human Skin Model Test using EpiSkin TM , EpiDerm TM and SkinEthic TM reconstructed human epidermal equivalents. For skin irritation, EpiSkin TM , EpiDerm TM and SkinEthic TM are validated as standalone test replacements for the rabbit Draize test. Data from these tests are rarely considered in isolation and are evaluated in combination with other factors to establish the overall irritating or corrosive potential of an ingredient. In light of the deadlines established in the Cosmetics Directive for cessation of animal testing for cosmetic ingredients, a COLIPA scientific meeting was held in Brussels on 30th January, 2008 to review the use of alternative approaches and to set up a decision tree approach for their integration into tiered testing strategies for hazard and safety assessment of cosmetic ingredients and their use in products. In conclusion, the safety assessments for skin irritation/corrosion of new chemicals for use in cosmetics can be confidently accomplished using exclusively alternative methods.
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Introduction
Skin irritation is defined as reversible damage of the skin following the application of a test substance for up to 4 h (Scientific Committee on Consumer Products (SCCP, 2006) ).
1 By contrast, skin corrosion is defined as ''irreversible damage to the skin, namely visible necrosis through the epidermis and into the dermis, following the application of a test substance for the duration period of 3 min up to 4 h (Organisation for Economic Co-operation and Development (OECD) Test Guideline (TG) 404). The potential of chemicals to cause acute skin irritation must be assessed as part of a basic toxicology program. Historically, the evaluation of the potential of a chemical to produce skin irritation has been carried out using the Draize skin irritation test in rabbits according to OECD TG 404 and Method B.4 of Annex V to Directive 67/548/EEC (OECD TG 404, 2002; EU, 1967) (Directive 67/548/EEC is now being replaced by regulations 1272/ 2008/EC (''EU-GHS" (Globally Harmonised System)) and 440/2008/ EC on test methods (EU, 2008a,b) ). The chemical is applied to the shaved area of skin and the appearance of oedema and/or erythema is determined up to 72 h after application. Despite the universal acceptance of this assay, the correlation between animal and human irritancy has come under question since there have been some cases where chemicals have been misclassified using in vivo rabbit data (Basketter et al., 1999; York et al., 1996) . The main reason for the discrepancy is thought to be related to a higher susceptibility of the rabbit to skin reactions, possibly due to differences in skin structure between humans and rabbits. The SCCP is the committee which provides the European Commission with scientific opinions on the safety of non-food consumer products, including cosmetics and therefore, alternative methods must also meet their acceptance criteria. The European Centre for the Validation of Alternative Methods (ECVAM), which is independent from the SCCP, was set up to ensure that alternative methods meet both scientific and regulatory approval. The acceptance of the methods depends on their validation as well as their long-term reproducibility and consistency (Rispin et al., 2004) . A number of alternative assays have been developed to determine the skin irritation potential of chemicals but the most significant milestone was the recent acceptance by the ECVAM Scientific Advisory Committee (ESAC) of the use of the EpiSkin TM reconstructed human epidermis (RHE), EpiDerm TM skin irritation test (SIT) and SkinEthic TM RHE in vitro skin models as validated stand-alone replacements for the rabbit Draize test, distinguishing between skin irritating (R38, similar to GHS Category 2) and non-irritating (no-label) chemicals (ESAC, 2008) .
On 11 March 2009, two bans entered into force concerning animal testing related to cosmetics products in the European Union. Both were decided in 2003 in the context of the 7th amendment to the Cosmetics Directive (EU, 1976) , which, amongst other purposes, aims at ensuring the safety of ingredients used in cosmetic products. A first ban concerns animal testing itself to assess the safety of ingredients. A second ban prohibits the sale of cosmetic products containing ingredients tested on animals. This ban is progressive, until it becomes a complete ban in March 2013 taking into account scientific progress being made regarding repeat dose tests for which alternative methods do not yet exist. The impact of the ban on the use of alternative assays to replace animal tests for the assessment of skin irritation after March 2009 was analysed at a COLIPA (The European Cosmetics Association) scientific meeting organised by its Safety Assessment and Skin Tolerance Project Teams in Brussels on 29th January, 2008. Participants included representatives from a number of cosmetic companies. Decision tree approaches to safety assessment of chemicals used in cosmetics were developed based on the discussions held during the workshop.
Results and discussion

Current alternative approaches to the assessment of skin irritation
Current safety assessment practice makes routine use of integrated testing strategies based on a Weight of Evidence (WoE) approach. WoE approaches have been in use for long and have also been investigated by ECVAM in the context of validation (Balls et al., 2006) . The principle is that all available information is considered in the assessment, in this case of skin irritation. Such information may include, for example:
Physicochemical properties. In silico methods. Historical in vivo animal data (including dermal toxicity data, data from skin sensitisation studies). In vitro data. Human data (clinical and post-market surveillance/history of safe use). Exposure. Tables 1 and 2 list some of the alternative skin models to identify skin corrosives (Table 1) and irritants (Table 2) , together with a brief description of the assays and the information that is obtained from them. In vitro methods for the assessment of corrosivity are already accepted and formally established as OECD guidelines for long and data from such assays have clearly their role in the testing strategy for skin irritation. Since the main focus of our investigation is the assessment of skin irritation, we concentrate here on assays for the assessment of skin irritation. Keratinocytes play an important role in the initiation, modulation and regulation of skin irritation (Coquette et al., 2000) , therefore, they have been central to the development of in vitro models to evaluate this effect. In contrast to some of the monolayer cell models, RHE models have a functional stratum corneum and can therefore be used to test neat (hydrophilic and hydrophobic) chemicals added directly to the stratum corneum. One main difference between the RHE models and normal human skin is the rate of penetration of chemical into the skin, which are higher in RHE skin equivalents than in human epidermis (Schäfer-Korting et al., 2008) . This difference gives rise to a higher sensitivity of the RHE models, however, this can be considered to be an advantage when testing mild irritants (Perkins Kaufmann et al. (2000) , Faller et al. (2002) , Hoffman et al. (2005) ; www.cellsystems.de; Spielmann et al. (2007) , Grindon et al. (2007) Reconstituted membrane barrier test: the Corrositex TM membrane barrier test Penetration of test substances through a hydrogenated collagen matrix (biobarrier) causing a colour change in the buffer below Identifies corrosives and non-corrosives. Overall predictivity of this model is low and the number of chemicals used in cosmetics which are qualified for testing using this assay are limited Stobbe et al. (2003) , Grindon et al. (2007) a Original references and reviews of different models for skin corrosion are cited. et al., 1999) . Unlike the in vitro corrosion RHE assays, the skin irritation RHE assays may include additional endpoints such as cytokine release e.g., IL-1a, a primary event in inflammation (Williams and Kupper, 1996; Spielmann et al., 2007; Coquette et al., 2003 Coquette et al., , 2005 Welss et al., 2004) . Some protocols use short incubation times of 4 h to mimic the in vivo human patch test , whereas others use longer times of 16 h (Faller et al., 2002) and 42 h (Spielmann et al., 2007) Welss et al. (2004) , some of which are shown in Table 2 . Table 3 outlines the regulatory status of in vitro skin irritation assays to detect corrosive and irritant chemicals. There are a number of validated in vitro assays to predict skin corrosivity and, to a lesser extent, skin irritation. Whilst the models listed are mainly used or validated for classification and labelling purposes, they can also be used as part of a safety assessment/benchmarking approach in consumer and occupational safety assessment. Currently, the ESAC fully endorses three in vitro skin irritation models, namely EpiSkin TM , EpiDerm TM and SkinEthic TM as stand-alone replacements for the Draize skin irritation test in animals. Moreover, these tests can be used as stand-alone tests to distinguish between skin irritating and non-irritating chemicals. The current SCCP statement (SCCP, 2007) welcomes the use of the EpiSkin TM model but still expresses concerns about the relevance of this test to assess the skin irritation potential of cosmetics. The concerns raised were twofold:
Alternative in vitro approaches already applicable for safety assessment
s The group of chemicals used to validate the assay, although included a large number of cosmetic ingredients, only contained one of the reference compounds listed in the Annexes to the Directive 76/768/EEC. The cosmetic industry has addressed this concern by submitting EpiSkin TM data on over 20 cosmetic ingredients included in the Annexes of the Cosmetics Directive. This dataset conclusively shows that regulated cosmetic ingredients belong to the application domain of the Episkin TM test method, and that predictive performance of this test is similar for such ingredients and chemicals in general. s Colouring chemicals that may interfere with the read-out system (MTT assay) need to have additional controls in order to take into account the non-specific optical density due to the residual test substance colour. An industry report addressing this issue has been submitted and is currently under review by the SCCP/SCCS. It shows that such interferences are overall infrequent and that when they occur, testing appropriate dilutions of the colouring materials permit to reduce this unspecific colouration to acceptable levels and to evaluate their skin irritation potential.
Alternative approaches not yet validated and/or under development 2.3.1. In vitro approaches
There are other in vitro skin irritation models which have not yet been formally validated or received regulatory acceptance but have proved useful in assessing the local tolerance of cosmetic ingredients using a WoE approach. Some of these are listed in Table 2 , however, it is recognised that this list is not exhaustive. There are other endpoints which are considered useful, such as IL-8 levels, lactate dehydrogenase release and histological analysis (Welss et al., 2004) .
In silico approaches
Computational models are available for Quantitative Structure Activity Relationships ((Q)SAR), incorporating physicochemical Lee et al. (2000) and other characteristics to predict the irritation potential of chemicals (http://ecb.jrc.ec.europa.eu/documents/QSAR/QSAR_ Review_Irritation.pdf). (Q)SARs are theoretical models that predict the ''approximate relationship between a biological property of a compound and its structure-derived physicochemical and structural properties" (Johnson and Maggiora, 1990) . A decision support system (DSS) developed by the German Federal Institute for Risk Assessment (BfR) uses physicochemical exclusion rules to predict the absence of skin irritation/corrosion potential in combination with structural inclusion rules (SARs) to predict the presence of such potential (Gerner et al., 2004a,b) . The exclusion rules are based on physicochemical properties such as molecular weight, Dropped from ECVAM validation study due to low predictive power Spielmann et al. (2007) Not accepted by regulatory authorities for identifying skin irritants Heylings et al. (2001 Heylings et al. ( , 2003 , Spielmann et al. (2007) aqueous solubility, and log Kow, whereas the inclusion rules are based on sub-structural molecular features. The physicochemical rules implicitly take into account bioavailability (skin penetration) whereas the structural rules take reactivity into account. The physicochemical and structural rulebases are designed to predict the EU risk phrases for skin irritation and skin corrosion. Further details are given in QSAR Reporting Format for the BfR skin and eye irritation rulebases. In one study focussing on esters (Smith et al., 2000) , the best variables correlating to human skin irritation were water solubility (lower for irritants than non-irritants), a dispersion parameter (higher for irritants), a hydrogen-bonding parameter (higher for irritants), the sum of partial positive charges (lower for irritants), and density (lower for irritants). There are a number of in silico models available and these are outlined in Table 4 . Data Table 4 In silico approaches used to predict skin irritation. The DSS SICRET (Skin Irritation Corrosion Rules Estimation Tool) model consists of a number of rules (known as the Gerner rules) based on physicochemical characteristics (such as melting point, logP and aqueous solubility) to exclude irritation, and structural alerts to include and predict corrosive chemicals (SICRET) and irritants Saliner et al. (2007) This model correctly predicted 99.3% non-corrosives and 96.6% nonirritants Saliner et al. (2007) Consideration of all available data, e.g.: Physicochemical properties Literature /animal/in vitro/human/ Read-across/SAR skin corrosivity testing Corrosive?
In vitro corrosivity test (Table 1) :
In vitro skin irritation test (Table 2) from in vitro methods can be used in combination with information on the physicochemical properties of the ingredient to provide information on its clinical tolerance. (Q)SARs might not constitute a full replacement by themselves, but they are valuable tools for screening and for prioritisation.
''Read-across" approach
The read-across approach uses the results obtained with a compound to predict the outcome of the effect of a chemically-related compound under evaluation. This may be based on chemical domain e.g., OECD Application Toolbox (www.oecd.org) or when animal data are available on similar substances. As with other end points (such as eye irritation) such evaluations are only possible when sufficient historical in vivo data for the chemical domain are available and there are no additional structural alerts that are considered likely to cause corrosive or irritant effects.
A tiered approach for skin irritation assessment
The OECD TG 404 recommends the use of a stepwise approach to evaluating the potential of a chemical to cause skin corrosion and/or irritation (OECD TG 404, 2002) . A decision tree strategy for testing skin corrosion and irritation potential has been outlined recently by Grindon et al. (2007) . Similarly, we have constructed two decision trees to aid approaches to using alternative models for hazard assessment (Fig. 1 ) and safety assessment (Fig. 2) of irritants. The decision trees can be used as a generic and broad overview of the type of questions needed to assess the potential hazard and the actual safety at usage levels. It should be kept in mind that it is not mandatory to carry out all the assays, rather they should be a guide as to what issues should be addressed, which assays could be used to resolve the issue and which extra assays could be used to add weight to the assessment.
Decision tree for hazard assessment
A decision tree for skin irritation hazard assessment is outlined in Fig. 1 . It should be noted that decisions in this tiered approach take into account assays that already have regulatory acceptance as well as those that are described in the scientific literature as being suitable. This is a tiered approach using different steps:
Step 1: The initial step in hazard identification is based on the physicochemical properties (e.g., pH) and other available data (e.g., (Q)SAR human and/or animal data) of the undiluted chemical to answer the question ''Does this chemical have the potential to be corrosive?". A compound is considered corrosive if indicated by the physicochemical properties. For example, strong acids (pH 6 2) or bases (pH P 11.5) are considered corrosive without the need for testing. If the answer to this question is ''yes", the chemical is corrosive and labelled accordingly (R34, similar to GHS Category 1). If the answer to this question is ''no", proceed to Step 2. If the WoE strongly indicates that the undiluted chemical is also not a skin irritant, by-pass Step 2 and proceed to Step 3 (indicated by the dotted lines).
Step 2: Conduct an in vitro corrosivity test to answer the question ''Is the corrosivity of the chemical confirmed?". Appropriate assays accepted by regulatory authorities for the identification of non-corrosive chemicals and mixtures are shown in Table 3 . If the outcome of this assay indicates that the chemical is corrosive, the labelling in Step 1 is confirmed. If the in vitro corrosivity test does not indicate corrosivity of the chemical, proceed to Step 3.
Step 3: Conduct an in vitro assay for skin irritation to answer the question ''Is the chemical a skin irritant?". Table 2 contains a list of assays that have been developed to evaluate skin irritation. Fig. 2 . Decision tree approaches to evaluate ingredients and final products for safety assessment based on hazard data for the neat ingredient.
The only regulatory accepted stand-alone assay to determine the skin irritant potential of a chemical is the in vitro EpiSkin TM assay. If the outcome of assay(s) identifies the chemical as an irritant, it is labelled accordingly (irritant, R38, similar to GHS Category 2). If the skin irritation test is negative, then the chemical is non-irritating (no labelling/not classified (NC)).
Decision tree for safety assessment
A decision tree for safety assessment of chemicals using alternative skin irritation models is outlined in Fig. 2 . At each step in safety assessment, a WoE approach (based on physicochemical properties and other available data) and read-across is recommended. Following the outcome of the hazard identification, there are three possible outcomes for safety assessment, namely, corrosive, irritant and non-irritating.
If the chemical is corrosive: A tiered approach using different steps is as follows:
Step 1: Conduct an in vitro corrosivity test using the relevant concentration of the chemical to answer the question ''Is the chemical corrosive at the relevant concentrations?". If the answer to this question is ''yes", then the chemical is not further considered for cosmetic use or can be further tested in the intended formulation. If the outcome of the formulation test for corrosivity is negative then proceed to
Step 2.
Step 2: Conduct an in vitro skin irritation test using the diluted chemical and/or the final formulation to ask the question ''Is the chemical an irritant at the relevant concentration?". If the answer to this question is ''yes", the chemical is an irritant. Depending on comparison with benchmark controls the decision can be made as to acceptability for market or re-formulation of the product. If the outcome is negative the chemical is not an irritant at relevant concentrations. Confirmatory human product testing can be considered to further specify non versus mild/moderate skin irritancy (see below for nonirritant scenario).
If the chemical is an irritant: follow Step 2 above. If the chemical is non-irritant: Currently, it is not possible to distinguish a mild/moderate irritant from a non-irritant in vitro (depicted in Fig. 2 with dotted lines) and assess the whole severity range of irritant responses of non-irritant chemicals. Therefore, confirmatory human product testing can be considered to further specify non versus mild/moderate skin irritancy. This could be patch testing or other appropriate in-use scenario test, considering a stepwise approach to concentrations.
Examples of the use of in vitro assays as part of the decision tree approach
Numerous citations in the literature state a good correlation between in vitro and clinical data. However, there is a regulatory concern that the skin in vitro assays are under-predicting positive responses. On the other hand there are reports that they might actually over-predict responses (van de Sandt et al., 1999; Spielmann et al., 2007) . One positive aspect of a model that over-predicts a response is that there are likely to be fewer false negatives. This was supported by the ECVAM validation study of the EpiSkin TM model, which predicted only a 1% frequency of false negatives compared to 22.9% of false positives, based on the data set generated in the evaluation (Spielmann et al., 2007) . Importantly, validated in vitro corrosivity and irritation tests using RHE skin models provide the same classification information for ingredients as the in vivo test. In-house validation studies of the SkinEthic TM RHE model and the SkinEthic TM Oral Mucosal Model (Rowland et al., 2003 (Rowland et al., , 2007 have shown promising results. These models are used routinely in-house to deliver clinical proof of principle at the earliest opportunity. Data generated from these models may be more clinically relevant than data derived from an animal study or human skin patch test, since preclinical or clinical results from these models are not always considered representative of the intended application or use of certain products, particularly in the instance of oral care applications. As a result of the confidence in the alternative models to predict skin irritation, they are already used to assess the safety of chemicals in certain cases. Other reasons for not using animal testing for safety assessment include:
s When the assessment is on finished products, which is banned (EU, 2003 The SCCP raised concerns about the applicability domain of the validated in vitro EpiSkin TM model (SCCP, 2007) , and these concerns are currently being addressed. Acceptance by the SCCP of EpiSkin TM data to predict the irritation potential of cosmetic ingredients can therefore be anticipated and to date there have been no comments on the other two models. In consideration of this point, the difference between qualification and validation requires clarification. Validation is needed for ECVAM approval as obtained for the EpiSkin TM model but qualification may only be needed for in-house verification that an in vitro assay is predicting clinical outcomes for the applied risk assessment purpose.
TTC-like approach
TTC-like approach refers to universal exposure thresholds of chemical exposure below which there is a low probability of an appreciable risk of skin irritation to humans (Kroes et al., 2004 (Kroes et al., , 2007 . It is a form of risk evaluation in which uncertainties based from data on other compounds are balanced against the low level of exposure (Munro et al., 2008) . The use of this approach should ideally be promoted and validated, especially for chemicals which are used at low concentrations. More concentrations for dose response correlations are needed to interpret irritation potency. This is because there may well be a threshold for this response, a fact that is crucial for safety assessment.
Cumulative irritation assays
Current alternative models address only acute skin irritation potential and not cumulative irritation potential. Cumulative irritation is more important for many of the cosmetic-type ingredients since the products tend to be used on a routine basis. However, the development of in vitro models for chronic irritation is challenging as it is not possible to culture/incubate cells for extended periods (days or weeks). Researchers have been trying to design and validate in vitro irritation assays to represent longer exposure periods which are representative of longer (chronic) exposure or to reflect exaggerated use (Rowland et al., 2003) . The SkinEthic TM RHE model has been used to compare irritation endpoints (modulation of cell viability, the release and gene expression of IL-1a and IL-8, and morphological changes) after a 72 h exposure period with irritation observed after 3 weeks in the clinical setting (de Brugerolle de . There was a good correlation between the in vitro and in vivo irritation potential, however, this model has not been validated. Similarly the validation of other biomarkers of irritation may need to be investigated, as reviewed by Welss et al. (2004) .
Exposure conditions
Extend the use of the in vitro methods to reflect the in vivo exposure conditions (e.g., rinse-off conditions). Some current dosing protocols include a rinse-off so that the reversibility of the irritation effect can be determined, for example, the validated EpiSkin TM protocol. The question arises as to whether the 'reversibility' is currently assessed by in vitro models and whether they could be adapted to do this. There may be differences of opinion as to whether this could be achieved, although an ECVAM report by van de Sandt et al. (1999) considered that one of the limitations of in vitro models was an inability to assess recovery.
Conclusions
Alternative models to the rabbit Draize test to detect skin irritants have been developed and used in the cosmetics industry for a number of years. The potential of a chemical to produce skin corrosion can be evaluated using the validated rat skin TER assay and the Human Skin Model Test (OECD TG 431, 2004) 2009/2013 , was that the good correlation between in vitro and in vivo skin irritation, together with the substantial in-house experience of these assays has given confidence in the outcomes of these assays such that in-house safety assessments on new products can be made without the use of animal testing. Decision tree approaches incorporating alternative models for skin corrosion and irritation can be used as a flexible guide for safety assessment, rather than a 'tick-box' approach. A decision tree for hazard assessment and labelling, using a WoE approach throughout, involves a step-wise evaluation of firstly, physicochemical characteristics, (Q)SAR and existing data, to identify and rule out corrosive chemicals for further testing; secondly, an in vitro corrosivity test; and finally, an in vitro irritation test to distinguish between irritants and non-irritants. Once a chemical has been classified as corrosive, irritant or a non-irritant, its safety assessment can also be evaluated using a second decision tree approach. Corrosive chemicals should be tested in an in vitro corrosivity test at the use concentration and, if shown to be non-corrosive, tested for irritation using an RHE in vitro irritation model. Chemicals labelled as irritants can be retested at the usage concentration, since they may not be irritants at lower concentrations or when used in the final formulation. Human confirmatory testing of the formulation is only carried out on a case-by-case basis. Future goals include providing further validation data requested by the SCCP to support their acceptance of EpiSkin TM ; proposing additional work on the TTC-like approach; extending in vitro models to include exposure levels (rinse-off); and development of in vitro models to reflect chronic exposure. In conclusion, the evaluation of the skin irritation potential of new chemicals for use in cosmetics can be confidently accomplished using only alternative methods.
